435 related articles for article (PubMed ID: 26515786)
21. Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia.
Vinciguerra L; Lanza G; Puglisi V; Pennisi M; Cantone M; Bramanti A; Pennisi G; Bella R
PLoS One; 2019; 14(4):e0216162. PubMed ID: 31017968
[TBL] [Abstract][Full Text] [Related]
22. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration.
Nardone R; Bergmann J; Kronbichler M; Kunz A; Klein S; Caleri F; Tezzon F; Ladurner G; Golaszewski S
J Neural Transm (Vienna); 2008 Nov; 115(11):1557-62. PubMed ID: 18841323
[TBL] [Abstract][Full Text] [Related]
23. Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait.
Picillo M; Dubbioso R; Iodice R; Iavarone A; Pisciotta C; Spina E; Santoro L; Barone P; Amboni M; Manganelli F
J Neural Transm (Vienna); 2015 Nov; 122(11):1533-40. PubMed ID: 26228625
[TBL] [Abstract][Full Text] [Related]
24. Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment: a TMS study.
Nardone R; Bergmann J; Kunz A; Christova M; Brigo F; Tezzon F; Trinka E; Golaszewski S
Sleep Med; 2012 Aug; 13(7):919-25. PubMed ID: 22726269
[TBL] [Abstract][Full Text] [Related]
25. Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer's disease.
Freitas MID; Porto CS; Oliveira MO; Brucki SMD; Mansur LL; Nitrini R; Radanovic M
Acta Neurol Belg; 2018 Sep; 118(3):465-473. PubMed ID: 30027378
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
27. Cholinergic neurotransmission and olfactory function in obstructive sleep apnea syndrome: a TMS study.
Versace V; Langthaler PB; Sebastianelli L; Golaszewski S; Kunz AB; Brigo F; Saltuari L; Nardone R
Sleep Med; 2017 Sep; 37():113-118. PubMed ID: 28899520
[TBL] [Abstract][Full Text] [Related]
28. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
[TBL] [Abstract][Full Text] [Related]
29. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
Kim SH; Kang HS; Kim HJ; Moon Y; Ryu HJ; Kim MY; Han SH
J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological assessment and cerebral vascular disease: the new standards.
Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
[TBL] [Abstract][Full Text] [Related]
31. Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia.
Nardone R; Marth R; Ausserer H; Bratti A; Tezzon F
Clin Neurophysiol; 2006 Oct; 117(10):2204-10. PubMed ID: 16931146
[TBL] [Abstract][Full Text] [Related]
32. Relationship between small cerebral white matter lesions and cognitive function in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Makino T; Umegaki H; Suzuki Y; Yanagawa M; Nonogaki Z; Nakashima H; Kuzuya M
Geriatr Gerontol Int; 2014 Oct; 14(4):819-26. PubMed ID: 24215176
[TBL] [Abstract][Full Text] [Related]
33. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients.
Sachdev PS; Brodaty H; Valenzuela MJ; Lorentz L; Looi JC; Wen W; Zagami AS
Neurology; 2004 Mar; 62(6):912-9. PubMed ID: 15037692
[TBL] [Abstract][Full Text] [Related]
34. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
[TBL] [Abstract][Full Text] [Related]
35. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease.
Manganelli F; Vitale C; Santangelo G; Pisciotta C; Iodice R; Cozzolino A; Dubbioso R; Picillo M; Barone P; Santoro L
Brain; 2009 Sep; 132(Pt 9):2350-5. PubMed ID: 19584099
[TBL] [Abstract][Full Text] [Related]
36. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
[TBL] [Abstract][Full Text] [Related]
37. A combined TMS-EEG study of short-latency afferent inhibition in the motor and dorsolateral prefrontal cortex.
Noda Y; Cash RF; Zomorrodi R; Dominguez LG; Farzan F; Rajji TK; Barr MS; Chen R; Daskalakis ZJ; Blumberger DM
J Neurophysiol; 2016 Sep; 116(3):938-48. PubMed ID: 27226450
[TBL] [Abstract][Full Text] [Related]
38. Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration.
Manganelli F; Ragno M; Cacchiò G; Iodice V; Trojano L; Silvaggio F; Scarcella M; Grazioli M; Santoro L; Perretti A
Clin Neurophysiol; 2008 Feb; 119(2):351-5. PubMed ID: 18065265
[TBL] [Abstract][Full Text] [Related]
39. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
Lim JS; Kwon HM; Lee YS
Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
[TBL] [Abstract][Full Text] [Related]
40. LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment.
Di Lorenzo F; Motta C; Casula EP; Bonnì S; Assogna M; Caltagirone C; Martorana A; Koch G
Brain Stimul; 2020; 13(5):1175-1182. PubMed ID: 32485235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
